The ruling will come into effect on January 1, 2025.

This happened at the same time that the UAE Cabinet approved the creation of a health insurance programme for domestic workers and employees of the private sector who do not currently have coverage. While granting or renewing their residency permits, employers of domestic workers in the nation will be obligated to cover the health insurance of their registered employees.

Employers are currently required by law to provide health insurance to their staff members in Abu Dhabi and Dubai. The mandatory programme in the UAE Capital provides coverage for staff members and their families.

The country’s sizable private sector workforce will have access to high-quality healthcare thanks to the new UAE-wide programme. The scheme will be implemented by the Ministry of Human Resources and Emiratisation (MoHRE) through the launch of pertinent awareness campaigns and programmes.

In the UAE, employees are now required to carry insurance for the second time. Employees had to enrol in a programme in 2023 to safeguard themselves against losing their jobs. Currently, the programme has over Seven and a half million registered employees from the federal government and private sectors.

The Workers’ Protection Programme covers 98% of the UAE workforce, according to Sheikh Mohammed bin Rashid, Vice-President and Prime Minister, who presided over the Cabinet meeting. The programme safeguards employees’ pay and other obligations if their employers file for bankruptcy.

“Today, we approved a new structure for the MoHRE, including establishing a coordinating council for the labour market in the UAE, to maintain its stability and enhance its competitiveness. The workforce is the real engine of the economy, and monitoring their concerns and protecting their rights are essential elements for advancing our national economy,” Sheikh Mohammed said, as reported by the Zawya.

Insurance Sector’s Take On The Government Move

As per a report from the Gulf News, experts in the insurance sector saw the government directive bringing numerous advantages for the sector stakeholders.

“For employees, it ensures guaranteed coverage; for insurance companies, it translates to increased revenues, and their risk pools will expand; and for the healthcare sector, it offers an incentive to enhance healthcare infrastructure nationwide,” the report stated further.

“Premiums may rise initially, especially in Sharjah due to its large population and associated cost of living, but should stabilise over time once businesses adjust to this new operational expense,” an insurance broker told Gulf News.

With Dubai’s population projected to reach 5.8 million by 2040 from the current 3.5 million and the UAE’s overall population expected to reach 11.1 million, analysts see insurers’ risk pools expanding further.

“This expansion will include newly arriving residents who need insurance under the new mandate. This broader risk distribution may lead to more stable or even reduced premiums as the risk is spread across a larger population base,” said Vijay Valecha, Chief Investment Officer of Century Finance, while interacting with the Gulf News.

Noting that a more significant risk pool should ideally mean a lower premium, Ramzi Ghurani, Managing Partner at Petra Insurance, remarked, “Theoretically, the decision to make insurance mandatory for all private sector employees should reduce premiums. However, insurance company prices are based on prices of hospitals and doctors. Unless that’s controlled, premiums may remain the same.”

Also, given the increased influx of new customers, an increase in competition may unfold in the insurance market, which may intensify the competition among insurers further.

“In a competitive market, insurers may strive to attract and retain customers by offering competitive premiums and enhanced benefits,” Valecha said.

Another insurance provider told the Gulf News the unification of health services was crucial for the industry, addressing anti-selection issues.

The broker said, “It would also improve healthcare quality, promote preventative measures, and attract medical investments. It would also result in the expansion of medical services in other Emirates like Al Ain and Ajman and increase job creation.”

The post UAE’s latest health insurance directive: All you need to know appeared first on International Finance.

Murshed Al Redaini, group chief executive officer of Yas Holding, told the media, “IDS provides a robust platform that complements our strengths in the pharmaceutical sector. This investment also underscores our commitment to the UAE Vision 2030 and is in line with our focus to establish a well-entrenched healthcare business. We are confident IDS’ business operations will synergise appreciably with our other healthcare companies.”

IDS was established in 1968 and it partners with leading multinational corporations in the UAE to supply a diverse product portfolio across a range of therapeutic classes like antibacterial, asthma, hypertension, diabetes, muscle relaxant, cardiovascular, anticoagulant, anti-rheumatic, and others.

The company also has a proven track record of creating significant long-term value by successfully integrating acquisitions into its growing portfolio of assets. This latest acquisition aligns with the company’s overall strategy and brings attractive opportunities offering substantial synergies.

Since its inception, the company has expanded significantly and has also acquired Gulf Inject, Geltec Healthcare and WellPharma Medical Solutions (WMS) in 2021. GHH’s portfolio includes biopharma, manufacturing, medical supply chain, hospital and clinic management, healthcare technology, and occupational health and wellness. Yas Holding has 7,500 employees and more than 60 operating subsidiaries and has expanding business interests in agriculture, food, healthcare, education, aviation, real estate, FMCG, technology & services.

The post YasHoldings acquire Al Ittihad drugstore to boost its healthcare portfolio appeared first on International Finance.

Nemaura Medical has developed an innovative device that can track diabetes with the help of blood-glucose levels. The device, named sugarBEAT comes with continuous glucose monitoring. The product was initially launched in the UK market and provides an alternative to people who are suffering from diabetes and want a needle-free alternative to keep a track of their blood-glucose level.

Upon the release of the device, the company initially placed an order of 200,000 sugarBEAT sensors in the UK and has predicted a sale of $2.1 million this year. After primarily receiving positive feedback from UK, the company revealed its plans to expand its markets and launch the product in Germany, the UAE, and Saudi Arabia.

Dr. Faz Chowdhury, the chief executive officer of Nemaura Medical, told the media, “We believe our technology is ground-breaking and represents a paradigm shift in the way people with diabetes can manage their condition. We believe we have a critical first-mover advantage with a product that is easier to use, more flexible, and more cost-effective than existing technologies. We are not aware of any product of a similar nature in clinical studies or that has been submitted for regulatory approval.”

The post UK medtech Nemaura Medicals mulls Middle East expansion appeared first on International Finance.

Maria de Freitas, co-founder and chief executive officer at uMore told the media, “We are very excited about the opportunity that TheVentureCity gives us, not only to validate our work but also to scale at super-sonic speed.”

“What we’re most looking forward to is that the program has a product-led growth approach, and that’s strongly aligned with our values. At uMore, we learn by continuously iterating, which allows us to test our hypotheses in real-time. We invest in experiences to drive growth, and we prioritise impact over effort. We believe that together with TheVentureCity’s global community of best-in-class, technology-focused mentors, the sky is the limit.”

Launched in December 2020, uMore is a digital health screening and recommendation platform. It uses machine learning and digital phenotyping to provide accessible and personalised mental health care to its users. The platform has around 3,000 users and is one of the UAE’s Top 50 apps under Health and Fitness.

Last year, the UAE’s Ministry of Health and Prevention launched an AI-backed healthcare app during the Arab Health 2020 event, which was held at the Dubai World Trade Centre.

The UAE smart healthcare app facilitates communication between deaf and mute patients and medical practitioners. The UAE healthcare app is designed to help doctors and medical providers better understand the health conditions of such patients.

The post uMore becomes first UAE startup to join TheVentureCity accelerator appeared first on International Finance.

Even prior to the pandemic, the country was a major contributor to healthcare. According to KPMG, the UAE government contributed 66 percent of its total healthcare spending which stood at $15 billion in 2018. In the following year, the government outlays comprised approximately 70 percent of total GCC healthcare expenditure and the UAE government-funded approximately 69 percent of its total healthcare expenditure of $16 billion. According to GCC growth forecasts, contributions from the private sector are expected to grow at a compound annual growth rate (CAGR) of 7.4 percent compared to a CAGR of 4.9 percent for the government sector during the period between 2018 and 2022.

With the pandemic, the dynamics within the sector are dramatically changing. There is a drive to promote private spending in the healthcare sector by encouraging the adoption of public-private partnership (PPP) models. Since the public-private collaboration has worked well for the UAE, it could further drive the growth of the healthcare sector and prove to be a model for other economies, not only in the Middle East but across the world.

Why public-sector cooperation is key?
To ensure that the healthcare sector was sustainable and ready to tackle the problem of Covid-19, an important decision that the administration took was to promote partnerships between private and government healthcare institutions. One of the biggest challenges that the healthcare providers in the UAE needed to address was to test, identify, isolate and treat Covid-19 patients according to their conditions. In the initial days of the pandemic, this required huge manpower, funding and resources. The government in the UAE was quick to recognise this. The UAE has anticipated the need for testing in gigantic numbers and quarantining facilities. This is where public-private cooperation has helped the UAE healthcare sustain itself. Many private hospitals and healthcare firms in the UAE have stepped in. In May, the UAE achieved a milestone for carrying out the highest number of Covid-19 testing per capita in the world.

Working in close collaboration with the government, the private healthcare sector has brought in its expertise and manpower to fight the virus. What resulted was that the public sector joined forces with the private sector, setting up field hospitals for thousands of Covid-19 patients across the UAE, while private organisations have helped in managing those by providing human resources. With the public-private cooperation in the healthcare sector helping the UAE to fight the future, there is anticipation that the collaboration will see new advancements in the region. Many experts predict that such collaboration holds the key to the development and growth of the overall healthcare sector in the UAE.

Richard Stolz, Associate Director, Advisory, KPMG Lower Gulf told International Finance, that there is a drive to promote private spending in the sector by encouraging the adoption of public-private partnership (PPP) models. “One key driver for the promotion of private investments is the increased need to bring in niche healthcare sector skills, for example, cardiology, that are not yet widespread in the UAE,” he said. “From 2018 to 2022, private-sector healthcare spending is forecast to increase at a cumulative annual growth rate (CAGR) of 9.5 percent, compared with the government contribution growth rate of 4.4 percent.

“Growth is mainly supported by the rising emergence and support for PPP, as well as the increasing demand for treatment and hospital beds amongst an ageing population. Further, the privatisation of hospitals and mandatory medical insurance, especially in Dubai and Abu Dhabi, will likely encourage spending and contribute to a more integrated health system.”

To curb the spread of the virus, lockdown measures were introduced in the UAE and had forced citizens to follow social protocols. On the bright side, there was significant growth for digital health. Many healthtech companies rose during the period to fulfil the demand. For example, Meddy is a GCC-based healthcare firm that allows patients to find doctors, hospitals and book appointments with them through its web-based platform. In light of public-private cooperation in healthcare, Meddy’s Chief Executive Officer Haris Aghadi, told International Finance, that he firmly believes that public-private cooperation in healthcare holds the key for the sector’s development.

“I believe that the pandemic put us in such a situation that we had to come together as a nation to combat it. The healthcare sector in the UAE has witnessed significant growth over the past few years and for it to grow more, the government’s association is key—whether it is in keeping regulations favourable for the private sector, aiding in the healthcare setup, or diminishing problems as we are currently doing in the case of Covid-19,” Aghadi said. Another important aspect of the healthcare sector in the UAE is that most of the population comprises expats. Around 82 percent of physicians and 96 percent of nurses in the UAE are expatriates. Also, citizens above the age demographic of 50 years merely make up 5 percent of the population. This highlights the importance of grooming homegrown talents for the healthcare sector and it can be effectively achieved through public-private cooperation.

Tech innovation improves patient outcomes
KPMG, in its ‘Who cares, wins, the first edition of our UAE healthcare perspectives report’ said that digital innovation is a growing priority. In the present day, a rising number of technologies are disrupting the healthcare information technology (HIT) space and at a very rapid pace. On a global level, administrations are understanding the important aspects of HIT. Additional funds in the form of administration and private investors are being poured into developing technologies that deliver faster, cheaper and more accessible care—while keeping patients well informed. In the UAE, the government is leveraging healthtech and smart healthcare to promote an integrated experience and improve patient outcomes. In particular, the local government seeks to tackle lifestyle diseases putting the country’s healthcare system under pressure.

According to KPMG, the UAE accounts for approximately 26 percent of the total healthcare spend in the GCC. It is ranked among the top 20 countries in the world in healthcare spending per capita, at $1,200. In short, the UAE’s health regulators are increasingly considering the adoption of new smart technologies. A study published by PwC last year shows that 67 percent of consumers in the Middle East are willing to receive healthcare services through virtual means. Some of the UAE’s health regulators are increasingly considering the adoption of new, smart technologies to modernise the healthcare ecosystem. The country is predicted to add an additional $182 billion to its economy by 2035 on the back of accelerated artificial intelligent adoption, further contributing to its vision of becoming a leading, global technology hub for healthcare.

Stolz said, “New models of care are likely to emerge, for example, greater digitalisation with a focus on remote monitoring and consultation. Telehealth, the use of communication technologies to access healthcare remotely, is likely to be integrated into PPP models and government healthcare systems. We will see increased spending on healthcare R&D and innovation.” According to KPMG, the UAE government plans to prioritise fostering the development of future technologies. Regulatory authorities’ openness toward futuristic technologies and their application in the healthcare industry creates an agile environment.

Telehealth is a big game-changer
Telehealth is a game-changer and it is here to stay. Telehealth eliminates the need to physically visit a doctor’s clinic or the hospital and the pandemic has given this a significant push. To curb the spread of the virus, social distancing measures were introduced by the government and this has resulted in telehealth becoming an important communication and treatment tool during the Covid-19 pandemic.

Telehealth facilitates either a synchronous or asynchronous session between the patient and his doctor. Companies providing such services grew significantly in the last year globally. While many new startups providing telehealth services have sprouted since the beginning of last year, big players have also set up their telehealth platforms to tap into the growing segment.

Richard Stolz believes that digitalisation and telehealth have the potential to revolutionise the healthcare sector. Given the implementation of online collaboration tools and platforms driven by the outbreak of the Covid-19 pandemic, remote monitoring and consultation solutions will likely become predominant in the future healthcare landscape. Stolz said, “The UAE has witnessed multiple private-sector hospital players embark on the telehealth journey throughout 2020 – within a short time of the outbreak of the pandemic, several had set up digital telehealth offerings that were quickly absorbed by the market.”

“Patients can consult specialists from the comfort of their homes and offices, get e-prescriptions and sick leaves on their phones, and their medicines re-filled and delivered by the pharmacy to their doorstep,” Aghadi explained. “Telehealth has made treatment convenient for both the patient and the doctor, in terms of cost, effort and comfort.”

The UAE’s pronounced efforts in medical tourism
KPMG estimates the global health tourism industry to have generated revenues of approximately $32.5 billion in 2019 at a CAGR rate of 17.9 percent for the period 2013 to 2019. According to the World Tourism Organization (UNWTO), the medical tourism industry is expected to become a $207.9 billion industry by 2027, expanding at a CAGR of 21.1 percent. The growth is attributed to the growing middle-class populations, especially in regions such as Southeast Asia. Their ability to board a flight seeking medical treatment is enhancing medical tourism. Inbound medical tourism in the UAE has grown steadily. Visitors often arrive in the UAE seeking treatments such as surgery, rehabilitation and cosmetic corrections. Dermatology, orthopaedics and ophthalmology are in their prime at this point. According to the latest Medical Tourism Index Ranking, Dubai and Abu Dhabi ranked sixth and eighth for the best global destinations for medical tourism.

What makes the region attractive for medical tourism is its wider tourism ecosystem. The UAE has a strong tourism sector supported by its tourism attractions, hospitality, entertainment and the provision of world-class aviation and transport logistics. These factors, along with low cost contribute to the UAE’s growing medical tourism industry. KPMG said in its report that the average cost of a hip replacement in developed countries such as the USA and Switzerland is $26,500 and $19,722 respectively; however, when it comes to the UAE, the same procedure costs under $15,000. On the downside, the UAE exhibits higher costs of medical treatments and services compared to countries such as India, Thailand and Singapore, which could push local patients to seek treatments abroad, KPMG said in its report.

Aghadi explained that Dubai is the top Arab destination for medical tourism. It is slowly becoming the hub for offering world-famous treatments with its high-end facilities and medical staff. This in return is boosting the healthcare industry in the region more than ever. “Licenced healthcare professionals are becoming skilled; the entire experience is no less than a vacation with a bonus for travellers as well. And it is important not to forget the economic boost, increase in local employment, and improved tourism activity, with the government’s focus on aiding and improving the healthcare sector in the country,” Aghadi added.

Work models likely to change for greater digitisation
Certainly, healthcare in the UAE remains one of the fastest-growing sectors. This is attributed to the growing number of hospitals and clinics in the country. Aghadi said that in some ways, the pandemic has acted as a catalyst for the healthcare sector in the country. Stating Meddy’s example, he said that within a time frame of two weeks, their team created a HIPAA compliant, which is a telehealth platform that allows patients to access doctors on video calls from anywhere, at any time. “The entire process of consulting the doctor from the payment to the follow-up was shifted online. Similarly, pharmaceutical companies have been in a rush to develop, clinically test, and supply vaccines,” Aghadi further explained. “However, alongside the quick innovation and collaborative problem solving, the virus has left the healthcare industry drained—overworked staff, lesser space, higher costs, and unemployment are just a few of the issues which have arisen during the outbreak. This pandemic has allowed the healthcare sector to always be ready for the future.”

The level of merger and acquisition (M&A) activities not only in the UAE but across six countries of the GCC has increased significantly since last year. Due to the pandemic, many smaller private healthcare providers were hard hit by the lockdown and many of them were mandated to allocate resources to fight against Covid-19. This has to some degrees impacted their liquidity significantly and some were even on the brink of closing their business.

On the other hand, larger private healthcare groups acquiring smaller healthcare players seeking financing aid and support seemed to be a viable option to sustain themselves amid the pandemic. “Increased consolidation through merger and acquisition activity in the global and regional healthcare sectors, as smaller private healthcare groups increasingly face liquidity difficulties caused by the Covid-19 pandemic,” Stolz said, additionally pointing out the phased return of elective surgeries were postponed during the pandemic. Teleradiology and online pharmacy retail are witnessing unprecedented demand. An increasing number of citizens in the UAE are adopting these kinds of new services which were still relatively new to the sector.

The pandemic has also led to greater government focus on healthcare spending, in terms of emphasizing an efficient, robust and dependable healthcare sector for the welfare of its people. As a result, Stolz hopes that policies and decision-making will likely be conducted in a more efficient and coordinated manner. Additionally, the pandemic is anticipated to drive global intergovernmental collaboration. For example, the World Healthcare Organisation and other international and national healthcare authorities will jointly monitor the potential emergence of viruses, Stolz added.

“New models of care are likely to emerge, for example, greater digitalisation with a focus on remote monitoring and consultation. Telehealth, the use of communication technologies to access healthcare remotely, is likely to be integrated into PPP models and government healthcare systems. We will see increased spending on healthcare R&D and innovation,” he added.

The post Are private-public alliances the way forward in UAE healthcare? appeared first on International Finance.

With regard to the partnership with MBZUAI, Gareth Goodier, Group chief executive officer of SEHA told the media, “The integration of technology in the administrative and medical elements of healthcare is paving the way for a stronger healthcare ecosystem, introducing opportunities for streamlined processes, transformative research, elevated patient experience, and ultimately, a more cost-effective industry.

“The potential for AI in healthcare is vast, and by partnering with MBZUAI, we are committed to exploring its limitless possibilities in medical research, early detection and diagnosis, decision making, and treatment, as we strive towards fostering the foundations of a robust healthcare sector that meets the UAE’s community’s every need with world class, unparalleled expertise.

Recently, it was also reported that Abu Dhabi-based holding company ADQ is merging its healthcare support service entities, Rafed and Union71, within Pure Health. As per the agreement, ADQ will transfer its ownership to Pure Health and receive a stake in the new healthcare services provider.

In this context, Mohamed Hassan Alsuwaidi, chief executive officer of ADQ told the media, “This transaction provides a unique opportunity to create a platform for healthcare support services with greater scale and further synergies in delivering reliable and innovative medical screening and lab testing, medical equipment distribution and group purchasing organisation services.”

The post Abu Dhabi Health Services Company to integrate AI into healthcare appeared first on International Finance.

Dr. Farida Al Khaja, chief executive officer of Clinical Support Services and Nursing Sector at the DHA and Chairperson of the COVID-19 Vaccination Steering Committee has revealed that the Al Safa primary healthcare centre has been added to the six existing facilities, which are offering the vaccine for free.

The six centres that were offering the Pfizer-BioNTech vaccine in the region are  Zabeel primary health care centre, Al Mizhar primary health care centre, Nad Al Hamr primary health care centre, Al Barsha primary health care centre, Uptown Miriff medical fitness centre and Hatta Hospital.

DHA has begun the vaccination drive for frontliners and employees in vital professionals in the government sector. In this regard, Dr Farida Al Khaja said, “These employees are public-facing employees, we are truly thankful to all frontliners across all sectors. We have received the list of these employees after coordination with relevant stakeholders across all government departments and we have booked their appointments.”

“In the first phase, Emiratis, as well as residents above the age of 60 years, people of determination, people with chronic diseases, frontliners in the public and private sector and people in occupations with the highest Covid-19 risk, are eligible. In the next phase, other segments of society will be eligible.”

The post DHA announces new centre offering the Pfizer-BioNTech vaccine appeared first on International Finance.

The new centre will be set up in Rashid Hospital. Both parties will also work to further enhance the services of the respiratory medicine department and the respiratory pulmonary laboratory at the Rashid Hospital.

The agreement was signed at the DHA’s headquarters in Dubai by Ahmed Al Nuaimi, chief executive at Joint Corporate Support Services at the DHA and Salah Amin, chief executive at Emirates Islamic Bank. Humaid Al Qutami, director-general of the DHA and Hesham Abdulla Al Qassim, chairman of Emirates Islamic Bank were also present.

Salah Amin told the media, “We are proud to contribute to Dubai Health Authority and support the strategic development plans of Rashid Hospital, one of the UAE’s leading healthcare providers. As  one of the country’s leading Islamic banks, Emirates Islamic is committed to supporting the development of UAE’s healthcare sector in delivering world-class health services that exceed patient expectations and the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of UAE and Ruler of Dubai, to position the UAE as a global healthcare hub of the wider Middle East region and beyond.”

Earlier this year, the UAE’s Ministry of Health and Prevention launched an AI-backed healthcare app during the Arab Health 2020 event. The UAE healthcare app is designed to help doctors and medical providers further understand the health conditions of such patients.

The post DHA, Emirates Islamic to set up dermatology and cosmetology centre appeared first on International Finance.

The terms of the transactions were not disclosed.

With regard to the investment in PCI Pharma, head of Pharma & Medtech at Mubadala, Camilla Macapili Languille told the media, “Outsourced pharmaceutical services has been a key investment theme for us over the past few years, and we are excited to be partnering with one of the global leaders in this industry.

“We have been particularly impressed by the quality and depth of PCI’s management team, as well as the company’s strong execution track record, impeccable values, and distinct vision for the long-term development of their business. We have strong conviction in the company’s growth trajectory and are committed to working with Kohlberg and Partners Group to ensure their long-term success.”

The Philadelphia-headquartered company spans a global footprint of 25 facilities across six countries and employs 3,900 people worldwide.

Through the investment in PCI Pharma, Mubadala expects to improve its customer service experience and enable its customers to bring lifesaving biopharmaceutical therapies to market.

Earlier this year, Mubadala Investment Company acquired a 1.85 percent stake in India’s Reliance Jio in a deal worth $1.21 billion.

Launched in 2016, Reliance Jio has established itself as a telecom giant in India in a short spell due to its competitive pricing strategy. Backed by multibillionaire Mukesh Ambani’s Reliance Jio disrupted the Indian telecom sector which led to many telcos exiting the market with Vodafone on the brink of shutting down its business in India.

The post Mubadala Investment Company invests in PCI Pharma Services appeared first on International Finance.

The healthcare fund will be launched by Mubadala’s venture capital arm and will invest in digital health technology and life science.Mubadala is expected to launch the healthcare fund in 2021.

Ibrahim Ajami, head of Mubadala Ventures told the media, “We are considering next year developing a sort of healthcare-specific fund that can be focused on life sciences and healthcare over the coming decade. Our view is that investments in this space are only going to accelerate moving forward.”

“It is proven now that one epidemic like this can bring down the entire world. The role of technology becomes very, very important, specifically in life sciences and the healthcare space.”

He further revealed that the size of the healthcare fund will be bigger than the funds earlier launched by Mubadala, such as the $437.24 million European fund last year.

Mubadala has also launched funds such as the $400 million US-focused fund and a $250 million Middle East and North Africa (MENA) fund in the last four years.

Mubadala has also invested in VIR Biotechnology, a healthcare firm that is developing a treatment for novel coronavirus, which has pushed the entire world in a state of lockdown.

Reportedly, Mubadala Investment Company is mulling investing in NMC Health, which is the UAE’s largest healthcare company. Mubadala is considering options such as buying a stake in NMC Health and also acquiring a board seat.

Mudabala’s decision to invest in NMC Health comes at a time when the healthcare company is undergoing an investigation by the UK’s Financial Conduct Authority over allegations of fraud.

The post Mubadala to launch a healthcare fund in light of Covid-19 outbreak appeared first on International Finance.